ChatGPT, an AI-based chatbot from OpenAI, has gone viral. Based on the company's GPT-3.5 large language model, ChatGPT is capable of some impressive feats. The company also has a large and diversified customer base, which could provide it with a competitive advantage in the AI market.
STOCKSTOWATCHTODAY BLOG Stock in Alibaba the Chinese e-commerce site, fell 7% in Hong Kong trading on Monday after reports the company is moving its headquarters out of the country. Alibaba (ticker: HK:9988) to be building a new campus in Singapore, according to the reports, which could become its global headquarters.
While every market advisor will tell you never to try to ‘time’ the market, timing is still important for success. Investors need to buy into low prices, and to do that, they need to know when prices are low. This doesn’t necessarily mean low in absolute dollar terms, but low relative to a stock’s recent past performance. In recognizing that lower price range, investors can turn to Wall Street’s pros for help. The analysts have been busy lately, picking out stocks that are in their lower price r
The Hang Seng tumbled as Chinese markets returned to trading after the New Year's holidays. Alibaba and some Adani-linked companies were under pressure.
The stock market would likely move higher if inflation cools off, but these two stocks could be big winners.
While 2022 was a year for stock price corrections across the electric vehicle (EV) sector, 2023 looks to be a transition year for the businesses themselves. Europe and China are leading the way, with fully electric vehicles accounting for 11% and 19% of all new vehicles sold, respectively. With stock prices down and sales continuing to pick up, investors should look at investing in a diverse mix of EV makers in 2023.
FTSE opened lower as investors brace for central bank decisions in the UK, eurozone and the US later this week.
Sales were crashing, earnings turned to losses, and the pain is likely to persist. You can understand why investors were not happy with Intel's (NASDAQ: INTC) fourth-quarter results. *Stock prices used were the afternoon prices of Jan.
(Bloomberg) -- Investors flocking to the equity rally will be disappointed as they’re in direct defiance of the Federal Reserve, according to Morgan Stanley strategists.Most Read from BloombergAdani Tries to Calm Investors With 413-Page Hindenburg RebuttalRussia Can’t Replace the Energy Market Putin BrokeAdani Rout Hits $72 Billion as Fight With Hindenburg IntensifiesFed Set to Shrink Rate Hikes Again as Inflation SlowsHistoric Crash for Memory Chips Threatens to Wipe Out Earnings“Better price a
Wall Street will be buzzing in the week ahead, as earnings from Big Tech, the Federal Reserve’s first meeting of the year, and the monthly jobs report for January set up the busiest week of the new year.
The Dutch technology-health company said its performance was hit by cost inflation that was partly offset by pricing and productivity measures.
Thinking about an investment property? You might want to think again.
(Bloomberg) -- Shares in Europe declined on Monday along with US equity futures as a note of caution crept in at the start of a week marked by interest-rate decisions and big-name company earnings on both sides of the Atlantic.Most Read from BloombergAdani Tries to Calm Investors With 413-Page Hindenburg RebuttalRussia Can’t Replace the Energy Market Putin BrokeAdani Rout Hits $72 Billion as Fight With Hindenburg IntensifiesFed Set to Shrink Rate Hikes Again as Inflation SlowsHistoric Crash for
Glide right into retirement.
'Because of the 2.5% rate, none of us are interested in selling the house and getting our rates jacked up to 7%.'
It was cheaper to fuel a gas-powered car for 100 miles than it was to charge a comparable electric vehicle in late 2022, according to Anderson Economic Group.
The stock is already down about 15% in 2023 as the pharmaceutical giant gets set to report earnings.
Investors should temper expectations, as this company's near-term success is largely out of its control.
Teladoc Health (NYSE: TDOC) sank 74% last year -- and for one particular reason. The telemedicine giant reported two billion-dollar noncash goodwill impairment charges. Both were linked to the acquisition of chronic-care specialist Livongo.